We correlated tumor stiffness (TS) measured with MR elastography (MRE) to degree of tumor enhancement and necrosis on contrast-enhanced T1-weighted imaging (CE-T1WI) in hepatocellular carcinomas (HCC) treated with locoregional therapy. Patients with HCC who underwent locoregional treatment and controls with newly diagnosed untreated HCC were included. TS values were obtained by placing regions of interest (ROIs) over HCCs on stiffness maps. Visual assessment of tumor necrosis on subtraction images and calculation of enhancement ratios by placing ROIs over tumors on CE-T1WI was performed. TS measured with MRE showed a significant correlation with tumor enhancement and necrosis.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords